Autologous hematopoietic stem cell transplantation in tandem with anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma.

被引：0
|
作者：
Yang, Xiuxiu [1 ]
Zhang, Peiling [1 ]
Cao, Yang [1 ]
Wang, Jue [1 ]
Zhou, Mi [1 ]
Li, Chunrui [1 ]
Zhou, Jianfeng [1 ]
Huang, Liang [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7532
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A New Promising Third Generation CAR-CD30 T-Cell Therapy for CD30+Lymphoma
    De Angelis, Biagio
    Guercio, Marika
    Orlando, Domenico
    Di Cecca, Stefano
    Sinibaldi, Matilde
    Boffa, Iolanda
    Caruso, Simona
    Abbaszadeh, Zeinab
    Camera, Antonio
    Biancamaria, Cembrola
    Bovetti, Katia
    Caruana, Ignazio
    Del Bufalo, Francesca
    Merli, Pietro
    Vinti, Luciana
    Girardi, Katia
    Ruggeri, Annalisa
    De Vito, Rita
    Quintarelli, Concetta
    Locatelli, Franco
    BLOOD, 2019, 134
  • [32] Combined autologous hematopoietic stem cell transplantation and CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma with TP53 mutation: A case report
    Cai, Ziyi
    Zou, Dongmei
    Ma, Qiang
    Sun, Wanling
    Guo, Yixian
    SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
  • [33] Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma
    Aldaoud, Ali
    DERMATOLOGIC CLINICS, 2008, 26 (01) : 15 - 17
  • [34] AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY PERIPHERAL T-CELL LYMPHOMA
    Shimizu, H.
    Hshimoto, Y.
    Yokohama, A.
    Saitoh, T.
    Handa, H.
    Irisawa, H.
    Jinbo, T.
    Murayama, K.
    Matsumoto, M.
    Sawamura, M.
    Tsukamoto, N.
    Murakami, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 638 - 638
  • [35] EFFICACY OF ESHAP REGIMEN IN THE ABSENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY T-CELL LYMPHOMA
    Norasetthada, L.
    Tantiworawit, A.
    Rattanathammethee, T.
    Hantrakool, S.
    ChaiAdisaksopha, C.
    Rattarittamrong, E.
    HAEMATOLOGICA, 2016, 101 : 696 - 696
  • [36] Pleiotropic effects of CD30-CD30L interaction on primary cutaneous CD30+ T-cell lymphomas.
    Mori, M
    Manuelli, C
    Pimpinelli, N
    Santucci, M
    Cappugi, P
    Giannotti, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 488 - 488
  • [37] Superior Therapeutic Index in Lymphoma Therapy: CD30+ CD34+ Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack
    Hombach, Andreas A.
    Goergens, Andre
    Chmielewski, Markus
    Murke, Florian
    Kimpel, Janine
    Giebel, Bernd
    Abken, Hinrich
    MOLECULAR THERAPY, 2016, 24 (08) : 1423 - 1434
  • [38] Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy
    Kawamoto, Keisuke
    Miyoshi, Hiroaki
    Suzuki, Takaharu
    Sasaki, Yuya
    Yamada, Kyohei
    Yanagida, Eriko
    Muto, Reiji
    Kiryu, Maiko
    Sone, Hirohito
    Seto, Masao
    Ohshima, Koichi
    Takizawa, Jun
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 166 - 173
  • [39] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    CANCERS, 2024, 16 (11)
  • [40] Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
    Kewalramani, Tarun
    Zelenetz, Andrew D.
    Teruya-Feldstein, Julie
    Hamlin, Paul
    Yahalom, Joachim
    Horwitz, Steven
    Nimer, Stephen D.
    Moskowitz, Craig H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 202 - 207
12345